Main Management ETF Advisors’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
OAM
DM
B
AIM
NAMA
Main Management ETF Advisors's CDNA Position: Q3 2025 in Review
Main Management ETF Advisors sold out of CareDx (CDNA) in Q3 2025, closing a stake of 36,650 shares — an estimated $716K sold.
Main Management ETF Advisors first reported a position in CDNA in Q3 2024 and held it in 4 quarters. The position peaked at $1.41M in Q3 2024. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.
- Main Management ETF Advisors reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
- Main Management ETF Advisors sold 36,650 CareDx shares in Q3 2025, an estimated $716K.
- Main Management ETF Advisors first reported a position in CareDx in Q3 2024 and held it in 4 quarters.
- Main Management ETF Advisors's CareDx position peaked at $1.41M in Q3 2024.
- 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.
Based on Main Management ETF Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.